Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
9,889 total articles
Black Stone Minerals, L.P. (NASDAQ:BSM) director D. Mark DeWalch recently purchased a substantial number of company common units. This transaction, totaling approximately $497,341, signals significant insider buying activity. Furthermore, recent financial reports for the first quarter of 2026 showed mixed results, with strong revenue performance bu…
Chief Global Commercialization Officer Anthony Mancini recently executed transactions involving Revolution Medicines, Inc. (NASDAQ:RVMD) common stock, selling shares under an established 10b5-1 trading plan. These sales occurred as the company's stock trades near its 52-week high. Beyond the insider activity, recent corporate developments include t…
Paul Schimmel, a director at aTYR Pharma Inc., recently purchased $49,630 worth of common stock. This activity occurs while the company progresses with drug development, including plans for a new Phase 3 study of efzofitimod. Furthermore, Jefferies maintained a Buy rating on the stock, citing potential shifts in medical practice.
Target executive Brian C. Cornell sold approximately $6.49 million worth of the company's common stock in transactions completed on May 27, 2026. This activity occurred as Target shares trade near $128.65, despite showing a 44% increase over the past six months. The report also details recent positive operational news for Target, including strong f…
Hartley R. Rogers, an executive co-chairman of Hamilton Lane INC (NASDAQ:HLNE), executed multiple transactions over May 26 and May 27, 2026, acquiring a substantial amount of the company's Class A Common Stock totaling $9,992,337. These significant insider purchases occurred while the stock was trading near its 52-week low. The timing of these acqu…
Caisse de depot et placement du Quebec (CDPQ) and its subsidiary sold a substantial block of shares in Zevia PBC. This transaction occurred while the company released strong financial results for the first quarter of 2026. Furthermore, Zevia announced key strategic updates, including an extension of its revolving credit facility with Bank of Americ…
Vicor Corporation's Vice President of Human Resources, Nancy L Grava, executed a series of transactions involving the sale of company common stock. These sales occurred against a backdrop of strong corporate performance for Vicor Corp. The company reported better-than-expected Q1 2026 earnings and has since raised its second-quarter revenue guidanc…
The recent activities of DoorDash's President and Chief Operating Officer, Prabir Adarkar, reveal a mix of selling and acquiring common stock. On May 26, 2026, Mr. Adarkar executed multiple sales totaling approximately $3.38 million in shares under an existing Rule 10b5-1 trading plan. Despite this executive divestiture, the company remains active …
John P. Zito, Co-President of Apollo Asset Management's parent company, sold a total of $6.35 million worth of common stock on May 27, 2026. These transactions occur against the backdrop of recent market activity and disappointing first-quarter earnings results for Apollo Global Management, Inc., which reported an EPS of $1.94 against projected $1.…
Mink Brook Asset Management LLC, which already holds a 10% ownership stake in DLH Holdings Corp., recently acquired an additional block of common stock. This buying activity occurs against the backdrop of mixed company performance, including a significant miss on second-quarter financial forecasts and existing analysis suggesting valuation discrepa…
Terrance P. Coyne, Executive Vice President and Chief Financial Officer of Royalty Pharma plc (NASDAQ:RPRX), sold a total of 64,399 Class A Ordinary Shares valued at approximately $3.48 million on May 26, 2026. This transaction was executed via a pre-arranged 10b5-1 trading plan and occurred while the stock traded near its recent 52-week high and f…
RLI Corp's leadership activity, highlighted by CEO Craig W. Kliethermes' purchase of company stock, signals internal confidence amidst various corporate actions. The company reported strong earnings per share in Q1 2026 but saw revenue miss projections. Despite this, RLI announced substantial dividend increases and authorized a significant repurcha…
The Chief Executive Officer of Twilio Inc., Khozema Shipchandler, executed a sale of company stock totaling approximately $5.97 million on May 26, 2026. This transaction involved the disposition of 32,158 shares of Class A Common Stock and was conducted under an established 10b5-1 trading plan following the exercise of employee options. Despite the…
Subir Dutt, Chief Sales Officer at Xometry Inc., executed a sale of company shares totaling $237,500. This transaction occurred as the stock trades near its 52-week high following significant gains. Separately, Xometry recently reported robust first quarter results and announced strategic appointments that underscore the company's involvement in th…
The recent activity by John T. Treace, Chief Executive Officer, Director, and a ten percent owner at Treace Medical Concepts, Inc. (NASDAQ:TMCI), indicates a substantial increase in his personal investment in the company. Over three transactions conducted between May 26 and May 28, 2026, Mr. Treace acquired a total of 115,520 shares of common stock…
George W. Cummings III, a director at Business First Bancshares, Inc., recently sold a significant block of company stock. This sale occurred against the backdrop of mixed first-quarter earnings for BFST, where the bank beat expectations on EPS but missed revenue targets. Despite this, Raymond James maintained an Outperform rating and price target,…
Sharon Spurlin, a director at Smart Sand, Inc. (NASDAQ:SND), recently sold 50,000 shares of common stock, totaling $246,500. This transaction occurs against the backdrop of significant stock price appreciation for SND. Separately, the company has reinforced its commitment to shareholder value by implementing a special cash dividend and adopting a n…
Watts Water Technologies Inc. (WTS) saw a reported insider transaction when Director Michael J. Dubose sold shares on May 28, 2026. This activity occurred against a backdrop of positive corporate developments, including the company's first-quarter 2026 earnings report, which surpassed analyst expectations for both EPS and revenue.
Charles Schwab Corp's leadership activity suggests internal confidence as CEO Richard A. Wurster acquired a substantial amount of common stock in May 2026. This buying spree occurs while the company is issuing significant senior notes and receiving positive revisions from major financial institutions, including price target increases and maintained…
COPT Defense Properties (NASDAQ:CDP) saw a director sell shares in late May. This transaction occurred against a backdrop of positive corporate news, including strong first quarter financial results and the declaration of an annualized dividend of $1.28 per share for the second quarter of 2026. The company's stock price is currently near its 52-wee…
Katayoun Motiey, Chief Legal Admin Sust Officer at Extreme Networks Inc. (EXTR), sold a total of 15,000 common shares valued at $397,500 on May 26, 2026. This sale was executed through a pre-arranged 10b5-1 trading plan adopted earlier in September 2025. These transactions occurred as EXTR stock trades near its annual high and has demonstrated sign…
Sanjit Biswas, the Chief Executive Officer of Samsara Inc. (NYSE:IOT), executed sales totaling approximately $8.07 million involving 263,900 shares of the company's Class A Common Stock between May 26 and May 28, 2026. These transactions were conducted through various trusts utilizing Rule 10b5-1 trading plans. Despite the executive sales, Samsara …
Cencora director D. Mark Durcan acquired a block of common stock, occurring while the company reported second-quarter financial results that missed expectations. Despite these earnings misses, Cencora announced key executive appointments and maintained its fiscal year guidance, leading to varied market reactions from analysts.
Ali-Jackson Kamil, a director at Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), executed a sale of common stock shares on May 26, 2026. This transaction occurred against a backdrop of positive corporate developments for Rigel, including significant first-quarter revenue increases and the securing of global licensing rights for a key oncology drug.
Chief Legal and Administrative Officer Todd M. Duchene sold a significant block of 10,000 shares of Core Scientific common stock, totaling $262,540, through a pre-arranged trading plan (Rule 10b5-1). This transaction occurs as the company's stock trades near its 52-week high. Separately, Core Scientific reported mixed Q1 2026 earnings and announced…
